Peptide‐Mediated Targeted Drug Delivery
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Targeting and Design".
Deadline for manuscript submissions: closed (31 May 2022) | Viewed by 2367
Special Issue Editor
Special Issue Information
Dear Colleagues,
Peptides are attractive carriers of diagnostic and therapeutic agents, and can improve the specificity and efficiency of their delivery into a given pathological tissue or cell. This property is largely attributed to selective binding to their receptor proteins, which may be biomarkers for the tissue or cells of interest. Peptide–receptor ligation can invoke downstream signaling cascades and/or trigger cellular transport processes for cargo intake and even exchange between cells. Phage display has been useful in discovering such peptide tools in a high-throughput manner, which may also lead to the identification of novel biomarkers for target protein/cell/tissue. Understanding how peptides function as therapeutics themselves or as delivery vehicles, and exploring new screening strategies, will shed light on cell biology and physiology, in addition to providing better ways to develop peptide-based delivery and therapeutic technologies.
This Special Issue highlights recent findings from top experts around the world on peptide-guided drug delivery and therapeutics development. Original research articles and reviews in the Issue will provide insights into peptide and biomarker discovery, cellular responses to peptide–receptor interactions, as well as preclinical and clinical applications of peptides in navigating molecular and nanoscale diagnostic and therapeutic payloads.
Dr. Hongbo Pang
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- peptides
- drug delivery
- endocytosis
- intercellular transport
- biomarkers
- diagnosis
- therapeutics
